Company: PFSA
Filing Date: 2025-02-12
Form Type: S-4/A
Source: 0001213900-25-012354
Chunk: 28

Company: Profusa, Inc.
Filing Date: 2025-02-12
Form: S-4/A
Chunk 28
---
 •the risk of downturns and the possibility of rapid change in the highly competitive industry in which Profusa operates; •the risk that Profusa and its current and future collaborators are unable to successfully develop and commercialize Profusa’s products or services, or experience significant delays in doing so; •the risk that the post -combinationcompany may never achieve or sustain profitability; •the risk that the post -combinationcompany will need to raise additional capital to execute its business plan, which may not be available on acceptable terms or at all; •the risk that the post -combinationcompany experiences difficulties in managing its growth and expanding operations; •the risk that third -partysuppliers and manufacturers are not able to fully and timely meet their obligations; •the risk that Profusa is unable to secure or protect its intellectual property; •the possibility that NorthView, Merger Sub or Profusa may be adversely affected by other economic, business, and/or competitive factors; and •other risks and uncertainties described in this proxy statement/prospectus, including those under the section entitled “ Risk Factors.” ix SUMMARY OF THE MATERIAL TERMS OF THE TRANSACTIONS This summary term sheet, together with the sections entitled “ Questions and Answers About the Proposals” and “ Summary of the Proxy Statement/Prospectus,” summarizes certain information contained in this proxy statement/prospectus, but does not contain all of the information that is important to you. You should read carefully this entire proxy statement/prospectus, including the attached Annexes, for a more complete understanding of the matters to be considered at the Special Meeting. In addition, for definitions used commonly throughout this proxy statement/prospectus, including this summary term sheet, see “ Frequently Used Terms.” •NorthView Acquisition Corporation, a Delaware corporation, which we refer to as “ NorthView,” “ we,” “ us,” or “ our,” is a special purpose acquisition company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar Business Combination with one or more businesses. •On December22, 2021, we consummated the IPO of 18,975,000 units at a price of $10.00 per unit (including 2,475,000 units from the full exercise of the underwriters’ over -allotmentoption), generating gross proceeds of $189,750,000. Simultaneously with the closing of the IPO, we consummated the sale of 7,347,500 private placement warrants to the Sponsor